These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8785428)

  • 1. Safety and regulation at the leading edge of biomedical biotechnology.
    Cohen-Haguenauer O
    Curr Opin Biotechnol; 1996 Jun; 7(3):265-72. PubMed ID: 8785428
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulatory framework of immunologicals in the European Union.
    Sauer F
    Biologicals; 1994 Dec; 22(4):307-11. PubMed ID: 7779353
    [No Abstract]   [Full Text] [Related]  

  • 3. Regulatory requirements for clinical trial and marketing authorisation application for gene therapy medicinal products.
    Schüle S; Renner M; Longhurst S; Narayanan G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Jan; 53(1):30-7. PubMed ID: 20012927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The procedure for marketing authorization for veterinary medicinal products derived from biotechnology in the European community.
    Brunko P
    Dev Biol Stand; 1992; 79():11-5. PubMed ID: 1286745
    [No Abstract]   [Full Text] [Related]  

  • 5. Opinion paper on the current status of the regulation of gene therapy in Europe.
    Cohen-Haguenauer O; Rosenthal F; Gänsbacher B; Bolhuis R; Dorsch-Häsler K; Eshhar Z; Gahrton G; Hokland P; Melani C; Rankin E; Thielemans K; Vile R; Zwierzina H; Cichutek K;
    Hum Gene Ther; 2002 Nov; 13(17):2085-110. PubMed ID: 12490003
    [No Abstract]   [Full Text] [Related]  

  • 6. Gene therapy: regulatory issues and international approaches to regulation.
    Cohen-Haguenauer O
    Curr Opin Biotechnol; 1997 Jun; 8(3):361-9. PubMed ID: 9206021
    [No Abstract]   [Full Text] [Related]  

  • 7. The limiting factor. Biotechnology and the charter for an international science and technology reference court.
    Zweig FM
    Not Polit; 2002; 18(65):51-8. PubMed ID: 15505917
    [No Abstract]   [Full Text] [Related]  

  • 8. Regulation of Agrobacterium gene manipulation.
    Dewhurst F
    Methods Mol Biol; 1995; 44():369-91. PubMed ID: 7581679
    [No Abstract]   [Full Text] [Related]  

  • 9. Tuft's report backs FDA fast-track, but post-marketing concerns loom.
    Vastag B
    Nat Biotechnol; 2006 May; 24(5):478. PubMed ID: 16680113
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical development of gene therapy needs a tailored approach: a regulatory perspective from the European Union.
    Narayanan G; Cossu G; Galli MC; Flory E; Ovelgonne H; Salmikangas P; Schneider CK; Trouvin JH
    Hum Gene Ther Clin Dev; 2014 Mar; 25(1):1-6. PubMed ID: 24649836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory concerns and prospects in the European Union: an industry view.
    Dickson A
    Curr Opin Biotechnol; 1996 Jun; 7(3):273-4. PubMed ID: 8785429
    [No Abstract]   [Full Text] [Related]  

  • 12. European Union guidance on the quality, safety and efficacy of DNA vaccines and regulatory requirements.
    Robertson JS; Cichutek K
    Dev Biol (Basel); 2000; 104():53-6. PubMed ID: 11713824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twenty Years of European Union Support to Gene Therapy and Gene Transfer.
    Gancberg D
    Hum Gene Ther; 2017 Nov; 28(11):951-953. PubMed ID: 28665213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comprehensive resource on EU regulatory information for investigators in gene therapy clinical research and advanced therapy medicinal products.
    Cohen-Haguenauer O
    Hum Gene Ther; 2013 Jan; 24(1):12-8. PubMed ID: 23339285
    [No Abstract]   [Full Text] [Related]  

  • 15. European Parliament axes patent policy.
    O'Brien C
    Science; 1995 Mar; 267(5203):1417-8. PubMed ID: 7878459
    [No Abstract]   [Full Text] [Related]  

  • 16. Human genetic technologies, European governance and the politics of bioethics.
    Salter B; Jones M
    Nat Rev Genet; 2002 Oct; 3(10):808-14. PubMed ID: 12360239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A blessing in disguise: international standards for the biotechnology industry.
    Lonien J
    Biotechnol J; 2012 Nov; 7(11):1321-3. PubMed ID: 23047846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Will stem cells create a market for human embryos?
    Kahn J
    J Androl; 2001; 22(1):12. PubMed ID: 11191076
    [No Abstract]   [Full Text] [Related]  

  • 19. EU wrangles internally over safety of donated tissues and cells.
    Vermij P
    Nat Biotechnol; 2003 Dec; 21(12):1420. PubMed ID: 14647315
    [No Abstract]   [Full Text] [Related]  

  • 20. EC prepares strategic vision for biotechnology.
    Mitchell P
    Nat Biotechnol; 2002 Feb; 20(2):107-8. PubMed ID: 11821842
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.